US Bancorp’s Wave Life Sciences WVE Stock Holding History
Bought
Maintained
Sold
Other funds holding WVE
RCM
GP
MC
DCM
6CM
RAM
US Bancorp's WVE Position: Q2 2026 in Review
US Bancorp reduced its Wave Life Sciences (WVE) stake by 100% in Q2 2026, selling an estimated $46.4K and leaving 30 shares worth $174. The position accounts for ﹤0.01% of the portfolio, ranked #4115.
US Bancorp first reported a position in WVE in Q1 2019 and has held it in 18 quarters since. The position peaked at $148K in Q3 2024. 239 funds tracked by Wall St. Rank hold WVE as of Q2 2026.
- US Bancorp held 30 shares of Wave Life Sciences worth $174 as of Q2 2026.
- US Bancorp sold 6,995 Wave Life Sciences shares in Q2 2026, an estimated $46.4K.
- Wave Life Sciences made up ﹤0.01% of US Bancorp's portfolio in Q2 2026, its #4115 holding.
- US Bancorp first reported a position in Wave Life Sciences in Q1 2019 and has held it in 18 quarters since.
- US Bancorp's Wave Life Sciences position peaked at $148K in Q3 2024.
- 239 funds tracked by Wall St. Rank held Wave Life Sciences as of Q2 2026.
Based on US Bancorp's 13F filing for Q2 2026, filed 12 Aug 2026.